Sale!

LRRC6 Gene Primary Ciliary Dyskinesia Type 19 Genetic Test

Original price was: $700.Current price is: $500.

-29%

The LRRC6 Gene Primary Ciliary Dyskinesia Type 19 NGS Genetic DNA Test is a comprehensive diagnostic tool that identifies mutations in the LRRC6 gene responsible for Primary Ciliary Dyskinesia Type 19. This advanced next-generation sequencing test provides crucial information for patients experiencing chronic respiratory infections, sinusitis, and fertility issues. By detecting specific genetic variations, the test enables accurate diagnosis, personalized treatment planning, and informed family planning decisions. The test costs $500 USD and is performed using state-of-the-art NGS technology, delivering results within 3-4 weeks. Our nationwide network of genetic specialists ensures accessible testing across all major US cities.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

LRRC6 Gene Primary Ciliary Dyskinesia Type 19 NGS Genetic DNA Test

Comprehensive Genetic Testing for Respiratory Health

The LRRC6 Gene Primary Ciliary Dyskinesia Type 19 NGS Genetic DNA Test represents a breakthrough in genetic diagnostics for respiratory disorders. This advanced test utilizes next-generation sequencing technology to identify mutations in the LRRC6 gene, which plays a critical role in ciliary function and respiratory health. Primary Ciliary Dyskinesia (PCD) is a rare genetic disorder affecting the structure and function of cilia – the microscopic, hair-like structures that line the respiratory tract and other organs.

What Does This Test Measure?

This comprehensive genetic analysis specifically targets the LRRC6 gene, which encodes a protein essential for proper ciliary assembly and function. The test detects:

  • Point mutations in the LRRC6 gene sequence
  • Insertions and deletions affecting gene function
  • Splice site variants that disrupt protein production
  • Copy number variations impacting gene dosage
  • Pathogenic variants associated with PCD Type 19

Who Should Consider This Test?

This genetic test is recommended for individuals experiencing symptoms consistent with Primary Ciliary Dyskinesia, including:

  • Chronic respiratory infections beginning in infancy
  • Persistent nasal congestion and sinusitis
  • Recurrent middle ear infections and hearing loss
  • Chronic cough with sputum production
  • Bronchiectasis confirmed by imaging studies
  • Neonatal respiratory distress without clear cause
  • Infertility issues in males due to sperm immotility
  • Family history of PCD or related respiratory conditions
  • Situs inversus (organs on opposite sides of the body)

Benefits of LRRC6 Genetic Testing

Undergoing this comprehensive genetic analysis provides numerous advantages for patients and healthcare providers:

  • Accurate Diagnosis: Confirms or rules out PCD Type 19 with high precision
  • Personalized Treatment: Enables targeted management strategies based on genetic findings
  • Family Planning: Provides crucial information for reproductive decision-making
  • Early Intervention: Facilitates proactive management to prevent complications
  • Genetic Counseling: Supports informed discussions about inheritance patterns
  • Research Contribution: Advances understanding of rare genetic disorders

Understanding Your Test Results

Your genetic test results will be thoroughly explained by our certified genetic counselors. Possible outcomes include:

  • Positive Result: Identifies pathogenic variants in the LRRC6 gene, confirming PCD Type 19 diagnosis
  • Negative Result: No disease-causing variants detected, though other genetic causes may need investigation
  • Variant of Uncertain Significance: Identifies genetic changes with unknown clinical impact requiring further evaluation
  • Carrier Status: Identifies individuals who carry one copy of a mutated gene but typically don’t show symptoms

Test Pricing and Details

Test Component Details
Test Name LRRC6 Gene Primary Ciliary Dyskinesia Type 19 NGS Genetic DNA Test
Discount Price $500 USD
Regular Price $700 USD
Turnaround Time 3 to 4 Weeks
Sample Type Blood, Extracted DNA, or One Drop Blood on FTA Card
Testing Method Next-Generation Sequencing (NGS) Technology
Specialty ENT Doctor, Genetics Department

Nationwide Testing Availability

We have established testing facilities across the United States, ensuring convenient access to advanced genetic diagnostics. Our network includes locations in:

  • New York City and surrounding metropolitan areas
  • Los Angeles and Southern California regions
  • Chicago and Midwest territories
  • Houston and Texas medical centers
  • Phoenix and Southwest facilities
  • All other major metropolitan areas nationwide

Take Control of Your Respiratory Health Today

Don’t let uncertainty about your respiratory symptoms continue. The LRRC6 Gene Primary Ciliary Dyskinesia Type 19 NGS Genetic DNA Test provides the clarity needed for proper diagnosis and management. Our team of genetic specialists, ENT doctors, and certified counselors are ready to support you through every step of the testing process.

Call or WhatsApp us today at +1(267) 388-9828 to schedule your appointment or book your test online. Take the first step toward understanding your genetic health and receiving personalized care tailored to your specific needs.